STIs in sex partners notified for chlamydia exposure: implications for expedited partner therapy.
Fleur van AarBirgit H B van BenthemIngrid V F van den BroekHannelore M GötzPublished in: Sexually transmitted infections (2018)
Implementing EPT without additional STI testing for all partners of chlamydia-infected index patients implies that STIs other than chlamydia will be missed. Although the chlamydia positivity rate was high among chlamydia-notified partners, two-thirds would unnecessarily use azithromycin. An evaluation of EPT against the current partner treatment strategy is needed to carefully weigh the potential health gains against the potential health losses and to explore the characteristics of EPT-eligible partners.
Keyphrases
- hiv testing
- men who have sex with men
- end stage renal disease
- healthcare
- public health
- human health
- mental health
- chronic kidney disease
- newly diagnosed
- risk assessment
- peritoneal dialysis
- health information
- climate change
- prognostic factors
- health promotion
- bone marrow
- hepatitis c virus
- human immunodeficiency virus